När var där senast en influensa på denna nivån där det blev fullt med skrämsel propaganda i median? när blev över 40 miljoner i USA vaccinerade senast med vaccin som gjorde att dom fick sluta att ge ut vaccinen på grund av att folk som fick vaccinen började att dö av dom?. och var startade den influensan jag pratar om? vid en militärbas som vanligt!.
Bayer ett företag i USA sålde vaccin med AIDS till barn medvetet, dom dödade människor världen runt med AIDS. stor skandal, inte hört talas om den?... sådana konspirationer händer hela tiden.
Ni vet säkert detta redan, hopppas jag, dom flesta som dör av influensa är redan sjuka och svaga!. efter ett vaccin är ditt immunförsvar svagare för du har blivit förgiftad, så risken ökar. där har varit många vetenskapliga studier som har kommit fram till att vaccinen inte skyddar en alls, alltså dom funkar inte, och att dom ger folk Alzheimers med mera.
"När allt fokus riktas mot en massvaccination mot svininfluensan riskerar den vanliga, mer dödliga, influensan att glömmas bort. Eventuella biverkninagar av det nya vaccinet talas det inte heller om. Och när influensavaccinationen huvudsakligen motiveras av den ekonomiska effekt infektionen skulle få mot industri och konsumtionssamhället så finns det all anledning att skärskåda insatsen, skriver läkaren Sven Britton." SvD.se
Här har ni några studier, gå in på länken för källor eller sök på google.
Two years ago a study in the British Medical Journal concluded that the effectiveness of annual flu shots has been exaggerated, and that in reality they have little or no effect on influenza campaign objectives, including reducing the number of hospital stays, time off work, and death from influenza and its complications.
Another study from 2005, published in the Archives of Internal Medicine also could not find support for the use of flu vaccine to prevent deaths in the elderly. The report highlights that although immunization rates in people over 65 have increased dramatically in the past 20 years, there has not been a consequent decline in flu-related deaths.
A recent study published in the October 2008 issue of the Archives of Pediatric & Adolescent Medicine found that vaccinating young children against the flu had no impact on flu-related hospitalizations or doctor visits during two recent flu seasons. The researchers concluded that "significant influenza vaccine effectiveness could not be demonstrated for any season, age, or setting" examined.
A study published in the Lancet just two months ago found that influenza vaccination was NOT associated with a reduced risk of pneumonia in older people. Vaccination coverage among the elderly increased from 15 percent in 1980 to 65 percent now, yet there has been no decrease in deaths from influenza or pneumonia.
That Lancet study supports a similar study done five years ago, published in The New England Journal of Medicine, which concluded that vaccination against pneumonia does not reduce your risk of contracting the disease.
Research published in the American Journal of Respiratory and Critical Care Medicine last month also confirms that there has been no decrease in deaths from influenza and pneumonia, despite the fact that vaccination coverage among the elderly has increased from 15 percent in 1980 to 65 percent now.
Last year, researchers with the National Institute of Allergy and Infectious Diseases, and the National Institutes of Health published this conclusion in the Lancet Infectious Diseases: “We conclude that frailty selection bias and use of non-specific endpoints such as all-cause mortality have led cohort studies to greatly exaggerate vaccine benefits.”
A large-scale, systematic review of 51 studies, published in the Cochrane Database of Systematic Reviews in 2006, found no evidence that the flu vaccine is any more effective than a placebo in children. The studies involved 260,000 children, age 6 to 23 months.
http://articles.mercola.com/sites/articles/archive/2008/11/18/do-flu-shots-work-ask-a-vaccine-manufacturer.aspx
Mitochondrial dysfunction, impaired oxidative-reduction activity, degeneration, and death in human neuronal and fetal cells induced by low-level exposure to thimerosal and other metal compounds.
Authors: D. A. Geier a; P. G. King b; M. R. Geier c
Affiliations: a Institute of Chronic Illnesses, Inc., Maryland, USA
b CoMeD, Inc., Maryland, USA c The Genetic Centers of America, Maryland, USA
Published in: Toxicological & Environmental Chemistry, Volume 91, Issue 4 June 2009 , pages 735 - 749
Abstract
"Thimerosal (ethylmercurithiosalicylic acid), an ethylmercury (EtHg)-releasing compound (49.55% mercury (Hg)), was used in a range of medical products for more than 70 years. Of particular recent concern, routine administering of Thimerosal-containing biologics/childhood vaccines have become significant sources of Hg exposure for some fetuses/infants. This study was undertaken to investigate cellular damage among in vitro human neuronal (SH-SY-5Y neuroblastoma and 1321N1 astrocytoma) and fetal (nontransformed) model systems using cell vitality assays and microscope-based digital image capture techniques to assess potential damage induced by Thimerosal and other metal compounds (aluminum (Al) sulfate, lead (Pb)(II) acetate, methylmercury (MeHg) hydroxide, and mercury (Hg)(II) chloride) where the cation was reported to exert adverse effects on developing cells. Thimerosal-associated cellular damage was also evaluated for similarity to pathophysiological findings observed in patients diagnosed with autistic disorders (ADs).
Thimerosal-induced cellular damage as evidenced by concentration- and time-dependent mitochondrial damage, reduced oxidative-reduction activity, cellular degeneration, and cell death in the in vitro human neuronal and fetal model systems studied. Thimerosal at low nanomolar (nM) concentrations induced significant cellular toxicity in human neuronal and fetal cells. Thimerosal-induced cytoxicity is similar to that observed in AD pathophysiologic studies. Thimerosal was found to be significantly more toxic than the other metal compounds examined. Future studies need to be conducted to evaluate additional mechanisms underlying Thimerosal-induced cellular damage and assess potential co-exposures to other compounds that may increase or decrease Thimerosal-mediated toxicity."
http://www.informaworld.com/smpp/content~content=a910652305~db=all~jumptype=rss
Här är några äldre studier som också visar hur giftigt det är (om det skadar hjärnorna på apor måste det vara jätte bra för barn!):
Comparison of Blood and Brain Mercury Levels in Infant Monkeys Exposed to Methylmercury or Vaccines Containing Thimerosal
This NIH-funded study, conducted by Dr. Thomas Burbacher, a University of Washington researcher, found that Thimerosal, best known for its use as an ethylmercury-based preservative in infant vaccines and pregnancy shots, is actually more toxic to the brain than methylmercury (MeHg).
http://www.nationalautismassociation.org/library/BurbacherThimFinal0405.pdf
A published study showing genetically susceptible mice will develop autistic symptoms when exposed to thimerosal.
Neurotoxic effects of postnatal thimerosal are mouse strain dependent.
http://www.nationalautismassociation.org/pdf/hornig.pdf
Thimerosal induces DNA breaks, caspase-3 activation, membrane damage, and cell death in cultured human neurons and fibroblasts.
Baskin Thimerosal Study 6/03
http://www.nationalautismassociation.org/library/BaskinThimerosalStudy6-03.pdf
Thimerosal Neurotoxicity is Associated with Glutathione Depletion: Protection with Glutathione Precursors. Jill James, et al - November 2004.
http://www.nationalautismassociation.org/library/James%20Neurotox%2011-04%20Thimerosal-Glutathione%20Depletion.pdf
Thimerosal-Containing Vaccines and Neurodevelopment Outcomes
Boyd Haley Affidavit 9/03
http://www.nationalautismassociation.org/library/BoydHaleyAFFIDAVITThimerosal9-03.pdf
This study presents the first epidemiologic evidence, based upon tens of millions of doses of vaccine administered in the United States, that associates increasing Thimerosal from vaccines with neurodevelopmental disorders.
http://www.nationalautismassociation.org/library/Geier1.pdf
